CVLB Conversion Labs Inc

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Strawn John R Jr	2. Issuer Name and Ticker or Trading Symbol LifeMD, Inc. [ LFMD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) C/O LIFEMD, INC., 800 THIRD AVE, STE 2800	3. Date of Earliest Transaction (MM/DD/YYYY) 4/18/2021
(Street) NEW YORK, NY 10022 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01	4/18/2021		M		200000	A	$1	203467 (1)	D
Common Stock, par value $0.01	4/18/2021		F		20060 (2)	D	$9.97	183407	D
Common Stock, par value $0.01	4/18/2021		M		100000	A	$2	283407	D
Common Stock, par value $0.01	4/18/2021		F		20060 (3)	D	$9.97	263347	D
Common Stock, par value $0.01								60000	I	Strawn Pickens LLP (4)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option	$1	4/18/2021		M			200000	4/20/2011	4/20/2021	Common Stock, par value $0.01	200000 (5)	$0	0	D
Option	$2	4/18/2021		M			100000	4/20/2011	4/20/2021	Common Stock, par value $0.01	100000 (6)	$0	0	D

Explanation of Responses:
(1)	The Amount of Securities Beneficially Owned reflects a correction of an additional 467 shares from previous Form 3/A filing of the reporting person.
(2)	Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 200,000 options pursuant to the Reporting Person's Stock Option Agreement.
(3)	Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 100,000 options pursuant to the Reporting Person's Stock Option Agreement.
(4)	Mr. Strawn has shared voting and dispositive power and as partner of Strawn Pickens LLP he shares a pecuniary interest. The shares were subject to a 1-for-5 reverse stock split in October, 2020.
(5)	The original grant of 1,000,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split.
(6)	The original grant of 500,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Strawn John R Jr C/O LIFEMD, INC. 800 THIRD AVE, STE 2800 NEW YORK, NY 10022	X

Signatures
/s/ John R. Strawn, Jr.		4/22/2021
**Signature of Reporting Person		Date